- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
20 days to go - register NOW!
Engineered Antibodies
13 - 14 June 2012, Hotel Palace Berlin, Berlin, Germany
|
Engineered Antibodies 2012 (formerly known as Recombinant Antibodies)- Europe's leading conference for discovering the latest in enabling technologies and engineering strategies for antibody enhancement
After popular demand we have re-vamped Recombinant Antibodies to Empowered Antibodies. Come and join us on our 11th year to discuss the latest technologies and strategies for engineering antibodies
Following on from the huge success of IBC’s Antibody Engineering and Antibody Therapeutics conference in San Diego in December, Informa Life Sciences are proud to announce the 11th anniversary of their sister European event.
Please join us to celebrate our anniversary in Berlin, June 2012. Engineered Antibodies 2012 is Europe’s leading industry conference covering every aspect of this exciting field, from antibody discovery and screening to analysis of their drug-like properties.
With so many events to choose from, we have worked hard to secure the very best speakers from the US and Europe, academia and industry. This is THE European event for the antibody community – do not miss out on this opportunity to network, forge strong relationships and collaborate with the pioneers of this field.
2012 Highlights of Informa's 11th Engineered Antibodies Conference
- Keynote presentation from Dr Dennis Burton, The Scripps Research Institute on developing Immunogens for eliciting antibodies for HIV protection read more
- Hear from Dyax and Adimab on structure-function dynamics read more
- Discover the latest in effector function enhancement and optimising half-life read more
- Optimise drug targeting and performance by hearing the cutting edge research and applications of alternative fragments and antibody formats read more
- Full session looking at applications and success of alternative scaffolds as enabling technologies read more
- Full day on the latest clinical data on recombinant antibodies being applied in the clinic read more
If you work at a university and wish to attend Engineered Antibodies 2012
You’ll be pleased to know we are offering a special 50% discount to all academic participants*.
What’s more, if you have cutting-edge data that you would like to share with the audience, you can do so by submitting a FREE poster to be presented in the exhibition hall. Make the most of this ONE-OFF opportunity to present you work in front of 150 scientists.
To take advantage of your 50% discount please contact Simon Lau, on +44 (0) 207 017 7165 or simon.lau@informa.com.
We look forward to seeing you there.
* 50% discount applies to top tier price only
30 industry and academic speakers from The Scripps Institute, NIH, ETH Zurich, Genentech, Merck & Co. and many more...
30 industry and academic speakers from The Scripps Institute, NIH, ETH Zurich, Genentech, Merck & Co. and many more...
Professor Dennis Burton
Department of Immunology and Microbial Science
Scripps Research Institute
|
Dr Dimiter Dimitrov,
Senior Investigator,
National Institute of Health, USA
|
Dr Peter Kiener
CEO
Zyngenia
|
Professor Dario Neri
Department of Chemistry & Applied Biosciences
ETH Zurich, Switzerland
|
Presentations from the following leading experts in the Antibody field...
- Professor Charles Coombes, Head, Division of Cancer, Imperial College London, UK
- Dr Christopher C. Broder, Professor, Microbiology and Immunology, Emerging Infectious Diseases, Department of Microbiology and Immunology, Uniformed Services University, USA
- Dr James Larrick, Managing Director, Panorama Research Insitute (PRI), USA
- Dr Robert Kelley, Senior Scientist, Antibody Engineering, Genentech, USA
- Dr Manuel Baca, Fellow, Antibody Discovery & Protein Engineering, MedImmune, USA
- Dr Andrew Nixon, VP, Discovery Research, Dyax, USA
- Dr Max Vasquez, VP, Computational Biology Department, Adimab, USA
- Dr Roger Beerli, Function Head, Human Monoclonal Antibodies, Intercell, Switzerland
- Dr Christopher Bond, Senior Scientist, Antibody Engineering, Oncomed, USA
- Dr Hilde Revets, Senior Research Fellow, Ablynx, Belgium
- Dr Catherine Hutching, Programme Leader, Antibodies, Heptares, UK
- Dr Serge Muyldermans, Professor, Cellular & Mooecular Immunology, Vrije Universiteit Brussel, Belgium
- Dr Patrick Chames, Main Scientist, INSERM, France
- Dr Arne Skerra, CEO, XL-Protein, Germany
- Dr Christophe Blanchetot, Research Fellow, ArGen-X, Belgium
- Dr Andreas Hohlbaum, Chief Technology Officer, Pieris AG, Germany
- Dr Johan Luthman, Senior Program Leader Neuroscience & Opthalmology R&D, Franchise Integrator,Merck & Co, USA
- Dr Oliver Schon, Programme Leader, Biopharm R&D Unit, GSK, UK
- Dr Daniel Steiner, Associate Director, Lead Identification, Molecular Partners, Switzerland
- Walter Ferlin, ESTM Department Head, NovImmune SA, Switzerland
Spotlight Session Sponsors
Media Partners at Recombinant Antibodies Conference
With nearly 100 participants, join our linked in group for Empowered Antibodies and start networking before the event and pose your questions to the experts!
6 reasons why Engineered Antibodies 2012 is a MUST ATTEND for 2012
Why should you attend Informa's 11th Annual Engineered Antibodies 2012 Conference?
*20 Expert Speakers representing all key stakeholders
*Coverage of key topics including, screening and structure-function dynamics, effector function enhancement, optimising half-life, alternative fragments anad scaffolds and clinical updates on RABs for a variety of diseases indications
*Choice of BRAND NEW Workshops and/or Evening Seminar & Networking Dinner
*Network with +150 scientists at the Empowered Antibodies Congress 2012
*Up to 10+ hours of dedicated networking time
*Structured poster session
And all in the vibrant city of Berlin
Plus don't miss 2 Interactive Workshops and a BRAND NEW Evening Seminar
Pre-Conference Symposium: Tuesday 12 June 2012
Antibody Generation and Screening Techniques
Evening Seminar, Discussion and Dinner: Wednesday 13 June 2012
Insight into the Pros and Cons of the Latest Novel Tools for Recombinant Antibody Engineering
Post-Conference Workshop: Friday 15 June 2012
Improving Antibody Drugability
Please download brochure for further details
Bio-Rad disclose end user presentation & IBIS Technologies announce presentation title
Our Congress sponsor Bio-Rad announce that DiaSorin Research Centre will be discussing their ProteOn™ XPR36 system during the following presentation presented by Dr. Carlotta Chiappa, Research Scientist, Antibody Development Unit, DiaSorin Research Centre DiaSorin SpA:
Multiple screening and selection of anti C. difficile Mabs using ProteOn™ XPR36: application for the development of a diagnostic test.
&
IBIS Technologies announce that Richard B.M Schasfoort at IBIS will present on:
The impact of the IBIS MX96 for label free screening; affinity and binning of engineered antibodies
To find out more about this presentation, click on the 'Presentation' tab above
Feeds | Like | Share    |
Dates and Venues
13 Jun 2012 - 14 Jun 2012
Hotel Palace Berlin, Berlin, Germany
Hear what past delegates had to say...
"Good overview of developments in recombinant antibodies, with strong focus on therapeutic applications"
"Nice mix of industry/ academic talks"
"Excellent snapshot of the field of antibody therapeutics"
